Merck buying Acceleron Pharma in $11.5B deal

- Advertisement -


Merck will spend about $11.5 billion to acquire Acceleron Pharma and treat high pressure in the vessels that carry blood from the heart to the lungs.

- Advertisement -

- Advertisement -

KENILWORTH, New Jersey — Merck will spend about $11.5 billion to acquire Acceleron Pharma and it’s treatment of high pressure in the vessels that carry blood from the heart to the lungs.

The company said Thursday that Merck will pay $180 in cash per share for each Acceleron share, Kenilworth, New Jersey.

- Advertisement -

The deal is expected to close in the fourth quarter.

.

- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox